nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—Vision blurred—Fingolimod—multiple sclerosis	0.0169	0.0311	CcSEcCtD
Methylscopolamine bromide—Palpitations—Fingolimod—multiple sclerosis	0.0159	0.0291	CcSEcCtD
Methylscopolamine bromide—Mydriasis—Prednisolone—multiple sclerosis	0.0158	0.0289	CcSEcCtD
Methylscopolamine bromide—Asthenia—Fingolimod—multiple sclerosis	0.0105	0.0193	CcSEcCtD
Methylscopolamine bromide—Dizziness—Fingolimod—multiple sclerosis	0.0097	0.0178	CcSEcCtD
Methylscopolamine bromide—Headache—Fingolimod—multiple sclerosis	0.00919	0.0169	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Mitoxantrone—multiple sclerosis	0.00885	0.0162	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Mitoxantrone—multiple sclerosis	0.00857	0.0157	CcSEcCtD
Methylscopolamine bromide—Confusional state—Cladribine—multiple sclerosis	0.00838	0.0154	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Cladribine—multiple sclerosis	0.00811	0.0149	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Prednisolone—multiple sclerosis	0.00794	0.0146	CcSEcCtD
Methylscopolamine bromide—Insomnia—Cladribine—multiple sclerosis	0.00752	0.0138	CcSEcCtD
Methylscopolamine bromide—Somnolence—Cladribine—multiple sclerosis	0.00739	0.0136	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Triamcinolone—multiple sclerosis	0.0073	0.0134	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Methylprednisolone—multiple sclerosis	0.00728	0.0134	CcSEcCtD
Methylscopolamine bromide—Constipation—Cladribine—multiple sclerosis	0.00711	0.013	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Cladribine—multiple sclerosis	0.00685	0.0126	CcSEcCtD
Methylscopolamine bromide—Urticaria—Cladribine—multiple sclerosis	0.0066	0.0121	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Mitoxantrone—multiple sclerosis	0.00631	0.0116	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Cladribine—multiple sclerosis	0.00612	0.0112	CcSEcCtD
Methylscopolamine bromide—Asthenia—Cladribine—multiple sclerosis	0.00596	0.0109	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Prednisone—multiple sclerosis	0.00577	0.0106	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Azathioprine—multiple sclerosis	0.00557	0.0102	CcSEcCtD
Methylscopolamine bromide—Confusional state—Mitoxantrone—multiple sclerosis	0.00551	0.0101	CcSEcCtD
Methylscopolamine bromide—Dizziness—Cladribine—multiple sclerosis	0.0055	0.0101	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00546	0.01	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Mitoxantrone—multiple sclerosis	0.00533	0.00978	CcSEcCtD
Methylscopolamine bromide—Vomiting—Cladribine—multiple sclerosis	0.00528	0.0097	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Prednisone—multiple sclerosis	0.00528	0.00968	CcSEcCtD
Methylscopolamine bromide—Headache—Cladribine—multiple sclerosis	0.00521	0.00955	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Prednisolone—multiple sclerosis	0.00518	0.0095	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Azathioprine—multiple sclerosis	0.00498	0.00913	CcSEcCtD
Methylscopolamine bromide—Nausea—Cladribine—multiple sclerosis	0.00494	0.00906	CcSEcCtD
Methylscopolamine bromide—Somnolence—Mitoxantrone—multiple sclerosis	0.00486	0.00891	CcSEcCtD
Methylscopolamine bromide—Constipation—Mitoxantrone—multiple sclerosis	0.00467	0.00857	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.0045	0.00826	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00448	0.00822	CcSEcCtD
Methylscopolamine bromide—Dizziness—Azathioprine—multiple sclerosis	0.00447	0.0082	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Methotrexate—multiple sclerosis	0.00441	0.00809	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Prednisolone—multiple sclerosis	0.00437	0.00803	CcSEcCtD
Methylscopolamine bromide—Urticaria—Mitoxantrone—multiple sclerosis	0.00434	0.00796	CcSEcCtD
Methylscopolamine bromide—Vomiting—Azathioprine—multiple sclerosis	0.0043	0.00788	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Methotrexate—multiple sclerosis	0.00427	0.00783	CcSEcCtD
Methylscopolamine bromide—Headache—Azathioprine—multiple sclerosis	0.00423	0.00777	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Triamcinolone—multiple sclerosis	0.00421	0.00771	CcSEcCtD
Methylscopolamine bromide—Confusional state—Methylprednisolone—multiple sclerosis	0.00415	0.00761	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00412	0.00756	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00411	0.00754	CcSEcCtD
Methylscopolamine bromide—Insomnia—Prednisolone—multiple sclerosis	0.00405	0.00744	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00403	0.00738	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Triamcinolone—multiple sclerosis	0.00402	0.00738	CcSEcCtD
Methylscopolamine bromide—Nausea—Azathioprine—multiple sclerosis	0.00401	0.00736	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Methylprednisolone—multiple sclerosis	0.00401	0.00736	CcSEcCtD
Methylscopolamine bromide—Asthenia—Mitoxantrone—multiple sclerosis	0.00392	0.00719	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Prednisone—multiple sclerosis	0.00376	0.0069	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00374	0.00686	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00374	0.00686	CcSEcCtD
Methylscopolamine bromide—Insomnia—Triamcinolone—multiple sclerosis	0.00373	0.00684	CcSEcCtD
Methylscopolamine bromide—Insomnia—Methylprednisolone—multiple sclerosis	0.00372	0.00682	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Prednisolone—multiple sclerosis	0.00369	0.00678	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Dexamethasone—multiple sclerosis	0.00365	0.0067	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Betamethasone—multiple sclerosis	0.00365	0.0067	CcSEcCtD
Methylscopolamine bromide—Urticaria—Prednisolone—multiple sclerosis	0.00356	0.00653	CcSEcCtD
Methylscopolamine bromide—Vomiting—Mitoxantrone—multiple sclerosis	0.00347	0.00637	CcSEcCtD
Methylscopolamine bromide—Headache—Mitoxantrone—multiple sclerosis	0.00342	0.00628	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Triamcinolone—multiple sclerosis	0.0034	0.00623	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00339	0.00622	CcSEcCtD
Methylscopolamine bromide—Insomnia—Betamethasone—multiple sclerosis	0.00338	0.00621	CcSEcCtD
Methylscopolamine bromide—Insomnia—Dexamethasone—multiple sclerosis	0.00338	0.00621	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Prednisolone—multiple sclerosis	0.0033	0.00606	CcSEcCtD
Methylscopolamine bromide—Urticaria—Triamcinolone—multiple sclerosis	0.00327	0.00601	CcSEcCtD
Methylscopolamine bromide—Urticaria—Methylprednisolone—multiple sclerosis	0.00327	0.00599	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Prednisone—multiple sclerosis	0.00326	0.00598	CcSEcCtD
Methylscopolamine bromide—Nausea—Mitoxantrone—multiple sclerosis	0.00325	0.00595	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Prednisone—multiple sclerosis	0.00318	0.00583	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Methotrexate—multiple sclerosis	0.00314	0.00577	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Betamethasone—multiple sclerosis	0.00308	0.00565	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00308	0.00565	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00304	0.00557	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00303	0.00556	CcSEcCtD
Methylscopolamine bromide—Urticaria—Dexamethasone—multiple sclerosis	0.00297	0.00545	CcSEcCtD
Methylscopolamine bromide—Urticaria—Betamethasone—multiple sclerosis	0.00297	0.00545	CcSEcCtD
Methylscopolamine bromide—Dizziness—Prednisolone—multiple sclerosis	0.00296	0.00544	CcSEcCtD
Methylscopolamine bromide—Asthenia—Triamcinolone—multiple sclerosis	0.00296	0.00543	CcSEcCtD
Methylscopolamine bromide—Asthenia—Methylprednisolone—multiple sclerosis	0.00295	0.00541	CcSEcCtD
Methylscopolamine bromide—Insomnia—Prednisone—multiple sclerosis	0.00295	0.0054	CcSEcCtD
Methylscopolamine bromide—Headache—Prednisolone—multiple sclerosis	0.00281	0.00515	CcSEcCtD
Methylscopolamine bromide—Constipation—Prednisone—multiple sclerosis	0.00279	0.00511	CcSEcCtD
Methylscopolamine bromide—Confusional state—Methotrexate—multiple sclerosis	0.00274	0.00504	CcSEcCtD
Methylscopolamine bromide—Dizziness—Triamcinolone—multiple sclerosis	0.00273	0.005	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00272	0.00499	CcSEcCtD
Methylscopolamine bromide—Dizziness—Methylprednisolone—multiple sclerosis	0.00272	0.00499	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Prednisone—multiple sclerosis	0.00268	0.00492	CcSEcCtD
Methylscopolamine bromide—Asthenia—Dexamethasone—multiple sclerosis	0.00268	0.00492	CcSEcCtD
Methylscopolamine bromide—Asthenia—Betamethasone—multiple sclerosis	0.00268	0.00492	CcSEcCtD
Methylscopolamine bromide—Nausea—Prednisolone—multiple sclerosis	0.00266	0.00488	CcSEcCtD
Methylscopolamine bromide—Vomiting—Triamcinolone—multiple sclerosis	0.00262	0.00481	CcSEcCtD
Methylscopolamine bromide—Vomiting—Methylprednisolone—multiple sclerosis	0.00262	0.0048	CcSEcCtD
Methylscopolamine bromide—Urticaria—Prednisone—multiple sclerosis	0.00259	0.00475	CcSEcCtD
Methylscopolamine bromide—Headache—Triamcinolone—multiple sclerosis	0.00258	0.00474	CcSEcCtD
Methylscopolamine bromide—Headache—Methylprednisolone—multiple sclerosis	0.00258	0.00473	CcSEcCtD
Methylscopolamine bromide—Dizziness—Dexamethasone—multiple sclerosis	0.00247	0.00454	CcSEcCtD
Methylscopolamine bromide—Dizziness—Betamethasone—multiple sclerosis	0.00247	0.00454	CcSEcCtD
Methylscopolamine bromide—Insomnia—Methotrexate—multiple sclerosis	0.00246	0.00452	CcSEcCtD
Methylscopolamine bromide—Nausea—Triamcinolone—multiple sclerosis	0.00245	0.00449	CcSEcCtD
Methylscopolamine bromide—Nausea—Methylprednisolone—multiple sclerosis	0.00244	0.00448	CcSEcCtD
Methylscopolamine bromide—Somnolence—Methotrexate—multiple sclerosis	0.00242	0.00444	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Prednisone—multiple sclerosis	0.0024	0.0044	CcSEcCtD
Methylscopolamine bromide—Vomiting—Dexamethasone—multiple sclerosis	0.00238	0.00436	CcSEcCtD
Methylscopolamine bromide—Vomiting—Betamethasone—multiple sclerosis	0.00238	0.00436	CcSEcCtD
Methylscopolamine bromide—Headache—Betamethasone—multiple sclerosis	0.00234	0.0043	CcSEcCtD
Methylscopolamine bromide—Headache—Dexamethasone—multiple sclerosis	0.00234	0.0043	CcSEcCtD
Methylscopolamine bromide—Asthenia—Prednisone—multiple sclerosis	0.00234	0.00429	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Methotrexate—multiple sclerosis	0.00224	0.00412	CcSEcCtD
Methylscopolamine bromide—Nausea—Betamethasone—multiple sclerosis	0.00222	0.00408	CcSEcCtD
Methylscopolamine bromide—Nausea—Dexamethasone—multiple sclerosis	0.00222	0.00408	CcSEcCtD
Methylscopolamine bromide—Urticaria—Methotrexate—multiple sclerosis	0.00216	0.00397	CcSEcCtD
Methylscopolamine bromide—Dizziness—Prednisone—multiple sclerosis	0.00215	0.00395	CcSEcCtD
Methylscopolamine bromide—Vomiting—Prednisone—multiple sclerosis	0.00207	0.0038	CcSEcCtD
Methylscopolamine bromide—Headache—Prednisone—multiple sclerosis	0.00204	0.00374	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Methotrexate—multiple sclerosis	0.00201	0.00368	CcSEcCtD
Methylscopolamine bromide—Asthenia—Methotrexate—multiple sclerosis	0.00195	0.00358	CcSEcCtD
Methylscopolamine bromide—Nausea—Prednisone—multiple sclerosis	0.00193	0.00355	CcSEcCtD
Methylscopolamine bromide—Dizziness—Methotrexate—multiple sclerosis	0.0018	0.0033	CcSEcCtD
Methylscopolamine bromide—Vomiting—Methotrexate—multiple sclerosis	0.00173	0.00318	CcSEcCtD
Methylscopolamine bromide—Headache—Methotrexate—multiple sclerosis	0.00171	0.00313	CcSEcCtD
Methylscopolamine bromide—Nausea—Methotrexate—multiple sclerosis	0.00162	0.00297	CcSEcCtD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TAGAP—multiple sclerosis	0.000701	0.00154	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000698	0.00153	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CCL5—multiple sclerosis	0.000696	0.00153	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—POMC—multiple sclerosis	0.000696	0.00153	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CCL5—multiple sclerosis	0.000694	0.00153	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CCL5—multiple sclerosis	0.000687	0.00151	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—CCL2—multiple sclerosis	0.000681	0.0015	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	0.000659	0.00145	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	0.000657	0.00144	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CNR1—multiple sclerosis	0.000655	0.00144	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	0.000651	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCL13—multiple sclerosis	0.00065	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCR1—multiple sclerosis	0.00065	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000649	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000644	0.00141	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000642	0.00141	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000635	0.0014	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.00063	0.00138	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000628	0.00138	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CCR5—multiple sclerosis	0.000627	0.00138	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CCR5—multiple sclerosis	0.000625	0.00137	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000622	0.00137	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—S1PR1—multiple sclerosis	0.000621	0.00137	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	0.000619	0.00136	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—S1PR1—multiple sclerosis	0.000619	0.00136	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	0.000613	0.00135	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GPC5—multiple sclerosis	0.000604	0.00133	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GPC5—multiple sclerosis	0.000602	0.00132	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000597	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—RRM1—multiple sclerosis	0.000597	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	0.000596	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CXCL10—multiple sclerosis	0.000589	0.0013	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000585	0.00129	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000583	0.00128	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000578	0.00127	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000565	0.00124	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000564	0.00124	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CCL5—multiple sclerosis	0.000559	0.00123	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000558	0.00123	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL3—multiple sclerosis	0.000552	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL3—multiple sclerosis	0.00055	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CCR2—multiple sclerosis	0.00055	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CCR2—multiple sclerosis	0.000548	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	0.000545	0.0012	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	0.000543	0.00119	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000536	0.00118	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PTGER4—multiple sclerosis	0.000532	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PTGER4—multiple sclerosis	0.00053	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RGS1—multiple sclerosis	0.000528	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RGS1—multiple sclerosis	0.000526	0.00116	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	0.000525	0.00115	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	0.000521	0.00115	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCR3—multiple sclerosis	0.000513	0.00113	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCR3—multiple sclerosis	0.000512	0.00113	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CNR1—multiple sclerosis	0.000508	0.00112	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCL5—multiple sclerosis	0.000507	0.00112	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	0.000507	0.00111	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CNR1—multiple sclerosis	0.000506	0.00111	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CCR5—multiple sclerosis	0.000503	0.00111	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	0.000501	0.0011	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GPR65—multiple sclerosis	0.000501	0.0011	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	0.000499	0.0011	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GPR65—multiple sclerosis	0.000499	0.0011	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCR2—multiple sclerosis	0.000498	0.00109	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000496	0.00109	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	0.000494	0.00109	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	0.000493	0.00108	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000492	0.00108	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	0.00049	0.00108	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.00049	0.00108	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—POMC—multiple sclerosis	0.000489	0.00107	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	0.000484	0.00106	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000482	0.00106	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	0.00048	0.00105	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—CCL2—multiple sclerosis	0.000478	0.00105	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	0.000473	0.00104	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL3—multiple sclerosis	0.000463	0.00102	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	0.000461	0.00101	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CNR1—multiple sclerosis	0.000459	0.00101	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	0.000458	0.00101	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	0.000458	0.00101	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCR5—multiple sclerosis	0.000457	0.001	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000457	0.001	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCR1—multiple sclerosis	0.000456	0.001	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL13—multiple sclerosis	0.000456	0.001	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000456	0.001	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	0.000455	0.001	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	0.000452	0.000994	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	0.000452	0.000994	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000451	0.000992	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL2RA—multiple sclerosis	0.00045	0.00099	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PTGER4—multiple sclerosis	0.000446	0.00098	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PGR—multiple sclerosis	0.000439	0.000966	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCR3—multiple sclerosis	0.000431	0.000947	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CD28—multiple sclerosis	0.000427	0.000938	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCR2—multiple sclerosis	0.000419	0.000921	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	0.000415	0.000912	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CXCL10—multiple sclerosis	0.000414	0.000909	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	0.00041	0.000901	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	0.000399	0.000876	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	0.000393	0.000865	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—POMC—multiple sclerosis	0.000393	0.000865	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CCL5—multiple sclerosis	0.000392	0.000862	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	0.000388	0.000854	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CNR1—multiple sclerosis	0.000387	0.00085	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000378	0.00083	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.000376	0.000828	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	0.000357	0.000785	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—POMC—multiple sclerosis	0.000357	0.000785	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	0.000356	0.000783	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	0.000354	0.000779	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	0.000353	0.000777	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	0.000353	0.000775	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	0.00035	0.000769	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CCL2—multiple sclerosis	0.00035	0.000768	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000349	0.000768	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CXCL10—multiple sclerosis	0.000348	0.000765	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000348	0.000765	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.000345	0.000758	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—BCHE—multiple sclerosis	0.000343	0.000753	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	0.000326	0.000717	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	0.000325	0.000715	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	0.000322	0.000708	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	0.000322	0.000707	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	0.000321	0.000705	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	0.000318	0.000698	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—TYK2—multiple sclerosis	0.000317	0.000698	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	0.000317	0.000697	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	0.000316	0.000695	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	0.000314	0.00069	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	0.000313	0.000688	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	0.000313	0.000688	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	0.00031	0.000681	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PGR—multiple sclerosis	0.000309	0.00068	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PGR—multiple sclerosis	0.000308	0.000678	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PGR—multiple sclerosis	0.000305	0.000671	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CD86—multiple sclerosis	0.000304	0.000669	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	0.000303	0.000667	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	0.000302	0.000665	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CD28—multiple sclerosis	0.0003	0.00066	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL5—multiple sclerosis	0.0003	0.000659	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CD28—multiple sclerosis	0.000299	0.000658	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	0.000299	0.000658	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CD28—multiple sclerosis	0.000297	0.000652	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	0.000295	0.000649	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	0.000294	0.000646	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	0.000291	0.00064	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—IL2—multiple sclerosis	0.000291	0.000639	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SPP1—multiple sclerosis	0.000278	0.00061	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	0.000277	0.000609	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	0.000276	0.000607	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	0.000273	0.000601	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	0.000272	0.000599	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	0.000271	0.000597	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCR5—multiple sclerosis	0.00027	0.000594	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	0.000269	0.000591	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL2RA—multiple sclerosis	0.000266	0.000585	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL2—multiple sclerosis	0.000264	0.000581	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	0.000252	0.000553	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	0.000251	0.000551	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	0.000248	0.000546	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	0.000246	0.000541	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—APOE—multiple sclerosis	0.000246	0.00054	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	0.000245	0.000539	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	0.000245	0.000539	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	0.000244	0.000537	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	0.000243	0.000534	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	0.000242	0.000532	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	0.000223	0.000491	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	0.000223	0.00049	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CD80—multiple sclerosis	0.000222	0.000488	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	0.000221	0.000485	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CD86—multiple sclerosis	0.000214	0.000471	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CD86—multiple sclerosis	0.000214	0.00047	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CD86—multiple sclerosis	0.000212	0.000465	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—POMC—multiple sclerosis	0.000211	0.000464	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	0.000211	0.000464	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	0.00021	0.000462	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	0.000208	0.000458	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CCL2—multiple sclerosis	0.000206	0.000454	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APOE—multiple sclerosis	0.000206	0.000453	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	0.000205	0.00045	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	0.000204	0.000449	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	0.000202	0.000444	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—MAPK1—multiple sclerosis	0.000202	0.000444	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	0.000195	0.00043	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	0.000195	0.000428	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	0.000193	0.000424	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	0.00019	0.000418	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	0.000189	0.000417	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	0.000188	0.000413	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TYK2—multiple sclerosis	0.000187	0.000412	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	0.000187	0.000412	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	0.000187	0.000411	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	0.000186	0.000409	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	0.000185	0.000407	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	0.000185	0.000407	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	0.000184	0.000404	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—POMC—multiple sclerosis	0.000177	0.000389	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—APOE—multiple sclerosis	0.000173	0.00038	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—APOE—multiple sclerosis	0.000172	0.000379	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—APOE—multiple sclerosis	0.000171	0.000375	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ALB—multiple sclerosis	0.000161	0.000355	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CD80—multiple sclerosis	0.000156	0.000344	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL2—multiple sclerosis	0.000156	0.000343	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CD80—multiple sclerosis	0.000156	0.000343	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	0.000155	0.000341	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CD80—multiple sclerosis	0.000154	0.000339	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—POMC—multiple sclerosis	0.000149	0.000327	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—POMC—multiple sclerosis	0.000148	0.000326	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	0.000148	0.000325	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—POMC—multiple sclerosis	0.000147	0.000322	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	0.000145	0.00032	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	0.000145	0.000319	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	0.000144	0.000315	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	0.000142	0.000313	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	0.000142	0.000312	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	0.00014	0.000309	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	0.000132	0.00029	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	0.000132	0.000289	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	0.000131	0.000289	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	0.00013	0.000286	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MYC—multiple sclerosis	0.000122	0.000268	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	0.000122	0.000268	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	0.000119	0.000262	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL2—multiple sclerosis	0.00011	0.000241	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL2—multiple sclerosis	0.000109	0.000241	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	0.000109	0.00024	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	0.000109	0.00024	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL2—multiple sclerosis	0.000108	0.000238	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	0.000108	0.000237	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	0.000104	0.000229	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	0.000104	0.000228	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	0.000103	0.000226	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	9.24e-05	0.000203	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	9.21e-05	0.000203	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—IL6—multiple sclerosis	9.17e-05	0.000202	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	9.12e-05	0.000201	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MYC—multiple sclerosis	8.59e-05	0.000189	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	8.57e-05	0.000188	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MYC—multiple sclerosis	8.56e-05	0.000188	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	8.54e-05	0.000188	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MYC—multiple sclerosis	8.48e-05	0.000186	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	8.46e-05	0.000186	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	8.4e-05	0.000185	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	8.38e-05	0.000184	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	8.29e-05	0.000182	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—IL6—multiple sclerosis	6.46e-05	0.000142	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—IL6—multiple sclerosis	6.44e-05	0.000141	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—IL6—multiple sclerosis	6.37e-05	0.00014	CbGpPWpGaD
